Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference.

Neoplasma - 1 Jan 2005

Li W T, Zhou G Y, Song X R, Chi W L, Ren R M, Wang X W

Abstract excerpt

Multidrug resistance (MDR) in human cancers is one of the major causes of failure of chemotherapy. The emergence of breast cancer resistance protein (BCRP), a member of the ABC transporter family, has necessitated the development of antagonists. To overcome the BCRP-mediated atypical multidrug drug resistance, two small interfering RNA constructs (RNAi) targeting two different regions of BCRP mRNA were designed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily G, Member 2
Share to ATP-Binding Cassette Transporters

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Survival

Share to Down-Regulation

Share to Drug Resistance, Multiple

Share to Mitoxantrone

Share to RNA Interference

Share to RNA, Small Interfering

Source

Identifiers

PMID: 15875083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference.PMID 15875083Read ↗

Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.Semantic proximity Read ↗

Atypical Multidrug Resistance: Breast Cancer Resistance Protein Messenger RNA Expression in Mitoxantrone-Selected Cell LinesSemantic proximity Read ↗

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).Semantic proximity Read ↗

Down Regulation of CIAPIN1 Reverses Multidrug Resistance in Human Breast Cancer Cells by Inhibiting MDR1Semantic proximity Read ↗

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug ResistanceSemantic proximity Read ↗

Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).Semantic proximity Read ↗

Gene therapy of the typical multidrug resistance phenotype of cancers: a new hope?Semantic proximity Read ↗

Modulation of breast cancer resistance protein (BCRP/ABCG2) gene expression using RNA interferenceSemantic proximity Read ↗

A multidrug resistance transporter from human MCF-7 breast cancer cellsSemantic proximity Read ↗

Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapySemantic proximity Read ↗

Recent attempts at RNAi‐mediated P‐glycoprotein downregulation for reversal of multidrug resistance in cancerSemantic proximity Read ↗

Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.